首页|低分子肝素钠联合黄体酮治疗妊娠早期先兆流产患者的效果

低分子肝素钠联合黄体酮治疗妊娠早期先兆流产患者的效果

扫码查看
目的:观察低分子肝素钠联合黄体酮治疗妊娠早期先兆流产患者的效果.方法:选取 2020 年 4 月至 2023 年 4 月该院收治的 116 例妊娠早期先兆流产患者进行前瞻性研究,按照随机数字表法分为研究组与对照组各 58 例.对照组采用黄体酮治疗,研究组在对照组基础上联合低分子肝素钠治疗,比较两组保胎成功率、凝血功能指标[血浆D二聚体(D-D)、纤维蛋白原(FIB)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)和凝血酶原时间(PT)]水平、激素[血清孕酮、雌二醇和人绒毛膜促性腺激素(HCG)]水平、阴道止血时间、腰腹疼痛缓解时间和不良反应发生率.结果:研究组保胎成功率为 96.55%,明显高于对照组的 86.21%,差异有统计学意义(P<0.05);治疗后,两组APTT、TT、PT长于治疗前,且研究组长于对照组,两组D-D、FIB水平低于治疗前,且研究组低于对照组,差异均有统计学意义(P<0.05);治疗后,两组血清孕酮、雌二醇、HCG水平高于治疗前,且研究组高于对照组,差异均有统计学意义(P<0.05);研究组阴道止血时间和腰腹疼痛缓解时间均短于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:低分子肝素钠联合黄体酮治疗妊娠早期先兆流产患者可提高保胎成功率以及血清孕酮、雌二醇、HCG水平,缩短阴道止血时间、腰腹疼痛缓解时间,改善凝血功能指标水平,效果优于单纯黄体酮治疗.
Effects of low molecular weight Heparin sodium combined with Progesterone in treatment of patients with threatened abortion in early pregnancy
Objective:To observe effects of low molecular weight Heparin sodium combined with Progesterone in treatment of patients with threatened abortion in early pregnancy.Methods:A prospective study was conducted on 116 patients with threatened abortion in early pregnancy admitted to the obstetrics department from April 2020 to April 2023.According to the random number table method,they were divided into study group and control group,58 cases in each group.The control group was treated with Progesterone,while the study group was treated with low molecular weight Heparin sodium on the basis of that of the control group.The success rate of tocolysis,the coagulation function indexes[plasma D-dimer(D-D),fibrinogen(FIB),activated partial thromboplastin time(APTT),thrombin time(TT)and prothrombin time(PT)]levels,the hormones[serum Progesterone,estradiol and human chorionic gonadotropin(HCG)]levels,the vaginal hemostasis time,the abdominal pain relief time,and the incidence of adverse reactions were compared between the two groups.Results:The success rate of tocolysis in the study group was 96.55%,which was significantly higher than 86.21%in the control group,and the difference was statistically significant(P<0.05).After the treatment,the levels of APTT,TT and PT in the two groups were longer than those before the treatment,and those in the study group were longer than the those in control group;the levels of D-D and FIB in the two groups were lower than those before the treatment,and those in the study group were lower than those in the control group;and the differences were statistically significant(P<0.05).After the treatment,the levels of serum Progesterone,estradiol and HCG in the two groups were higher than those before the treatment,those in the study group were higher than those in the control group,and the differences were statistically significant(P<0.05).The vaginal hemostasis time and the lumbar and abdominal pain relief time in the study group were shorter than those in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Low molecular weight Heparin sodium combined with Progesterone in the treatment of threatened abortion in early pregnancy can improve the success rate of tocolysis and the levels of serum Progesterone,estradiol and HCG,shorten the vaginal hemostasis time and the lumbar and abdominal pain relief time,and improve the levels of coagulation function indexes.Moreover,it is superior to simple Progesterone treatment.

Low molecular weight Heparin sodiumProgesteroneEarly pregnancyThreatened abortionHormoneCoagulation functionAdverse reaction

刘侠、白晓雪、谭皓

展开 >

河南省神火集团总医院妇产科,河南 商丘 476600

低分子肝素钠 黄体酮 妊娠早期 先兆流产 激素 凝血功能 不良反应

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(19)
  • 7